澳5彩票开户www.a55555.net)是澳洲幸运5彩票官方网站,开放澳洲幸运5彩票会员开户、澳洲幸运5彩票代理开户、澳洲幸运5彩票线上投注、澳洲幸运5实时开奖等服务的平台。

(L-R) Non-Independent Non-Executive Director of UMedic Group Berhad Lau Chee Keong, Non-Independent Non Executive Chairman of UMedic Group Berhad Dato Ng Chai Eng, Chairman of Affin Hwang Investment Bank Berhad YM Tunku Afwida Binti Tunku A. Malek, at the launching of its initial public offering prospectus in conjunction with its listing on the ACE Market of Bursa Malaysia Securities Berhad - FAIHAN GHANI/The Star

PETALING JAYA: Medical devices maker UMediC Group Bhd (UMC), which is slated for a listing on Bursa Malaysia’s ACE Market on July 26, aims to raise RM31.1mil from its initial public offering (IPO).

The company will allocate RM3.5mil from the gross proceeds to construct a new factory, while RM6.8mil will go for the setting up of new marketing and distribution offices.

A further RM9mil will be allocated to repay borrowings, and RM8.66mil will be used for working capital.

UMC’s executive director and group chief executive officer Lim Taw Seong said Malaysia’s medical device industry is expected to grow at a rate of 12.1% from 2021 to 2026.

“Supported by our strong track record, we have, over the years, cultivated and groomed a team of talented and dynamaic individuals comprising sales, medical and technical specialists,” he said.

He added that paired with the demand from its manufacturing segment, the company intends to utilise the IPO proceeds to construct a new factory to increase production capacity.

,

欧博手机版网址www.aLLbet8.vip)是欧博集团的官方网站。欧博手机版网址开放Allbet注册、Allbe代理、Allbet电脑客户端、Allbet手机版下载等业务。

,

With regards to the company’s manufactured medical consumables, Lim noted that there has been increased usage of disposable medical products to reduce the risks of cross-contamination, especially after the Covid-19 pandemic.

“Our management team foresees an untapped potential and we are poised to seize on these valuable opportunities,” he added.

Its IPO comprises a public issue of 97.22 million new shares at 32 sen per share. Out of this, 18.69 million shares will be made available to the Malaysian public and 13.08 million allocated to eligible directors, employees and business associates.

The remaining 65.44 million shares will be made available via private placements to selected investors.

Based on its enlarged share capital of 373.91 million shares and IPO price, the market capitalisation would be RM119.65mil.


转载说明:本文转载自Sunbet。 南昌新闻网声明:该文看法仅代表作者自己,与南昌新闻网无关。转载请注明:欧博手机版网址:UMediC aims to raise RM31mil from IPO
发布评论

分享到:

Telegram分享群组:投资小作文是口毒鸡汤 不能没监管
1 条回复
  1. 澳10官网(www.a55555.net)
    澳10官网(www.a55555.net)
    (2022-12-22 00:09:13) 1#

      在新冠疫苗接种方面,原案指出,将在确保安全性和有效性的前提下,在2021年上半年完成疫苗贮备,并逐步对高龄职员和医务工作者实行优先接种。很细腻的网文

发表评论

◎欢迎参与讨论,请在这里发表您的看法、交流您的观点。